ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use

A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents

Deepak L. Bhatt, James Scheiman, Neena S. Abraham, Elliott M. Antman, Francis K L Chan, Curt D. Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M. Quigley, Robert A. Harrington, Eric R. Bates, Charles R. Bridges, Mark J. Eisenberg, Victor A. Ferrari, Mark A. Hlatky, Sanjay Kaul, Jonathan Lindner, David J. Moliterno, Debabrata Mukherjee, Richard S. Schofield & 4 others Robert S. Rosenson, James H. Stein, Howard H. Weitz, Deborah J. Wesley

Research output: Contribution to journalArticle

364 Citations (Scopus)

Abstract

In appropriate patients, oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.

Original languageEnglish (US)
Pages (from-to)1894-1909
Number of pages16
JournalCirculation
Volume118
Issue number18
DOIs
StatePublished - Oct 28 2008
Externally publishedYes

Fingerprint

Non-Steroidal Anti-Inflammatory Agents
Advisory Committees
Consensus
Hemorrhage
Therapeutics
Pylorus
Primary Care Physicians
Ulcer
Communication

Keywords

  • AHA Scientific Statements
  • Antiplatelet therapy
  • Aspirin
  • Gastroduodenal ulcer
  • Gastrointestinal bleeding
  • Gastrointestinal risk
  • NSAID
  • Stents
  • Thrombosis

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use : A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents. / Bhatt, Deepak L.; Scheiman, James; Abraham, Neena S.; Antman, Elliott M.; Chan, Francis K L; Furberg, Curt D.; Johnson, David A.; Mahaffey, Kenneth W.; Quigley, Eamonn M.; Harrington, Robert A.; Bates, Eric R.; Bridges, Charles R.; Eisenberg, Mark J.; Ferrari, Victor A.; Hlatky, Mark A.; Kaul, Sanjay; Lindner, Jonathan; Moliterno, David J.; Mukherjee, Debabrata; Schofield, Richard S.; Rosenson, Robert S.; Stein, James H.; Weitz, Howard H.; Wesley, Deborah J.

In: Circulation, Vol. 118, No. 18, 28.10.2008, p. 1894-1909.

Research output: Contribution to journalArticle

Bhatt, DL, Scheiman, J, Abraham, NS, Antman, EM, Chan, FKL, Furberg, CD, Johnson, DA, Mahaffey, KW, Quigley, EM, Harrington, RA, Bates, ER, Bridges, CR, Eisenberg, MJ, Ferrari, VA, Hlatky, MA, Kaul, S, Lindner, J, Moliterno, DJ, Mukherjee, D, Schofield, RS, Rosenson, RS, Stein, JH, Weitz, HH & Wesley, DJ 2008, 'ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents', Circulation, vol. 118, no. 18, pp. 1894-1909. https://doi.org/10.1161/CIRCULATIONAHA.108.191087
Bhatt, Deepak L. ; Scheiman, James ; Abraham, Neena S. ; Antman, Elliott M. ; Chan, Francis K L ; Furberg, Curt D. ; Johnson, David A. ; Mahaffey, Kenneth W. ; Quigley, Eamonn M. ; Harrington, Robert A. ; Bates, Eric R. ; Bridges, Charles R. ; Eisenberg, Mark J. ; Ferrari, Victor A. ; Hlatky, Mark A. ; Kaul, Sanjay ; Lindner, Jonathan ; Moliterno, David J. ; Mukherjee, Debabrata ; Schofield, Richard S. ; Rosenson, Robert S. ; Stein, James H. ; Weitz, Howard H. ; Wesley, Deborah J. / ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use : A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents. In: Circulation. 2008 ; Vol. 118, No. 18. pp. 1894-1909.
@article{7ead0a874ecf4a628acbb3da93feb295,
title = "ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents",
abstract = "In appropriate patients, oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.",
keywords = "AHA Scientific Statements, Antiplatelet therapy, Aspirin, Gastroduodenal ulcer, Gastrointestinal bleeding, Gastrointestinal risk, NSAID, Stents, Thrombosis",
author = "Bhatt, {Deepak L.} and James Scheiman and Abraham, {Neena S.} and Antman, {Elliott M.} and Chan, {Francis K L} and Furberg, {Curt D.} and Johnson, {David A.} and Mahaffey, {Kenneth W.} and Quigley, {Eamonn M.} and Harrington, {Robert A.} and Bates, {Eric R.} and Bridges, {Charles R.} and Eisenberg, {Mark J.} and Ferrari, {Victor A.} and Hlatky, {Mark A.} and Sanjay Kaul and Jonathan Lindner and Moliterno, {David J.} and Debabrata Mukherjee and Schofield, {Richard S.} and Rosenson, {Robert S.} and Stein, {James H.} and Weitz, {Howard H.} and Wesley, {Deborah J.}",
year = "2008",
month = "10",
day = "28",
doi = "10.1161/CIRCULATIONAHA.108.191087",
language = "English (US)",
volume = "118",
pages = "1894--1909",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "18",

}

TY - JOUR

T1 - ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use

T2 - A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents

AU - Bhatt, Deepak L.

AU - Scheiman, James

AU - Abraham, Neena S.

AU - Antman, Elliott M.

AU - Chan, Francis K L

AU - Furberg, Curt D.

AU - Johnson, David A.

AU - Mahaffey, Kenneth W.

AU - Quigley, Eamonn M.

AU - Harrington, Robert A.

AU - Bates, Eric R.

AU - Bridges, Charles R.

AU - Eisenberg, Mark J.

AU - Ferrari, Victor A.

AU - Hlatky, Mark A.

AU - Kaul, Sanjay

AU - Lindner, Jonathan

AU - Moliterno, David J.

AU - Mukherjee, Debabrata

AU - Schofield, Richard S.

AU - Rosenson, Robert S.

AU - Stein, James H.

AU - Weitz, Howard H.

AU - Wesley, Deborah J.

PY - 2008/10/28

Y1 - 2008/10/28

N2 - In appropriate patients, oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.

AB - In appropriate patients, oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.

KW - AHA Scientific Statements

KW - Antiplatelet therapy

KW - Aspirin

KW - Gastroduodenal ulcer

KW - Gastrointestinal bleeding

KW - Gastrointestinal risk

KW - NSAID

KW - Stents

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=56749183852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749183852&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.108.191087

DO - 10.1161/CIRCULATIONAHA.108.191087

M3 - Article

VL - 118

SP - 1894

EP - 1909

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 18

ER -